Upload Avatar (500 x 500)
Baozhong Zhang
bz.zhang3@siat.ac.cn
Chinese, English
Guangdong
University of Chinese Academy of Sciences
Life Sciences
  • 2014-03--2017-12 PhD: University of Hong Kong
  • 2019-03~Present - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher
  • 2014-03~2017-12 - University of Hong Kong - PhD
  • Research Pioneer Award (2023): Institute (School)
  • Synthetic Institute Research Innovation Award, First Prize (2020): Institute (School)
Antibiotic-resistant bacteria
Vaccine development
  • Rational design of booster vaccine strain against COVID-19 based on antigenic distance, Baozhong Zhang, 2023
  • Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine, Baozhong Zhang, 2022
  • Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice, Baozhong Zhang, 2022
  • Adenosine synthase A contributes to recurrent Staphylococcus aureus infection by dampening protective immunity, Baozhong Zhang, 2021
  • A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters, Baozhong Zhang, 2021
  • Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against Klebsiella pneumoniae, Baozhong Zhang, 2021
  • Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients, Baozhong Zhang, 2020
  • SARS-CoV-2 infects human neural progenitor cells and brain organoids, Baozhong Zhang, 2020
Antibiotic Resistance Bacterial Infections Pathogens Microbiology Immunology Vaccine Research Public Health Infectious Diseases Biotechnology Medical Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.